Neurology
Conference Coverage
Opicapone increased on-time without dyskinesia in patients with Parkinson’s disease
PHILADELPHIA - Improvements of up to 2 hours were seen in an analysis of the BIPARK-1 and BIPARK-2 phase 3 studies.
Conference Coverage
Sleep apnea is linked with tau accumulation in the brain
Philadelphia – Study results suggest a mechanism for the observed association between sleep disruption and increased...
Conference Coverage
Medical cannabis relieved pain, decreased opioid use in elderly
Medical cannabis was an effective and well-tolerated treatment in an elderly cohort of patients with chronic pain.
Conference Coverage
Is pro soccer a risk factor for ALS?
A higher risk of ALS and an earlier age of onset was found among professional soccer players.
From the Journals
Few stroke patients undergo osteoporosis screening, treatment
Stroke patients are at increased risk of osteoporosis and fractures, yet few receive bone mineral density testing and treatment.
News from the FDA/CDC
CDC warns against misuse of opioid-prescribing guideline
Officials at the Centers for Disease Control and Prevention are advising against misapplication of the agency’s guideline on opioid prescribing....
Conference Coverage
In pain treatment, racial bias common among physician trainees
MILWAUKEE – Most residents and fellows who demonstrated racial bias did not report that race factored into treatment decisions.
News
FDA approves generic naloxone spray for opioid overdose treatment
The agency said the naloxone nasal spray does not need assembly and can be used by anyone, regardless of medical training.
Conference Coverage
No clear winner for treating neuropathic pain
PHILADELPHIA – More head-to-head trials of treatments for neuropathic pain are needed.
News
BACE-1 inhibition worsens cognition in patients with prodromal Alzheimer’s disease
Inhibiting the APP-cleaving enzyme decreased the toxic amyloid species, but it also worsened cognition and caused a variety of concerning adverse...
News
FDA to expand opioid labeling with instructions on proper tapering
The label changes are intended to be used when both the clinician and patient have agreed to reduce the opioid dosage.